Post-approval studies (Phase 4)Study completedNCT00299000
What this trial is testing
Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
Who this might be right for
Mucopolysaccharidosis VIMaroteaux-Lamy Syndrome
BioMarin Pharmaceutical 4